| (R)-adrenaline | multiple interactions | ISO | RGD:737467 | 6480464 | Epinephrine binds to and results in increased activity of ADRB3 protein | CTD | PMID:1682311 |
| (R)-adrenaline | multiple interactions | ISO | RGD:737467 | 6480464 | Epinephrine binds to and results in increased activity of ADRB3 protein | CTD | PMID:1682311 PMID:14730417 |
| (R)-adrenaline | multiple interactions | ISO | RGD:737467 | 6480464 | Epinephrine inhibits the reaction [cyanopindolol binds to ADRB3 protein]; more ... | CTD | PMID:14730417 |
| (R)-adrenaline | multiple interactions | ISO | RGD:737467 | 6480464 | Epinephrine binds to and results in increased activity of ADRB3 protein | CTD | PMID:14730417 PMID:1682311 |
| (R)-adrenaline | multiple interactions | EXP | | 6480464 | Epinephrine binds to and results in increased activity of ADRB3 protein | CTD | PMID:7815362 |
| (R)-noradrenaline | multiple interactions | ISO | RGD:737467 | 6480464 | Norepinephrine binds to and results in increased activity of ADRB3 protein | CTD | PMID:1682311 |
| (R)-noradrenaline | multiple interactions | ISO | RGD:737467 | 6480464 | Norepinephrine binds to and results in increased activity of ADRB3 protein | CTD | PMID:14730417 PMID:1682311 |
| (R)-noradrenaline | increases activity | EXP | | 6480464 | Norepinephrine results in increased activity of ADRB3 protein | CTD | PMID:8569714 PMID:17622774 |
| (R)-noradrenaline | multiple interactions | ISO | RGD:737467 | 6480464 | Norepinephrine inhibits the reaction [cyanopindolol binds to ADRB3 protein]; more ... | CTD | PMID:14730417 |
| (R)-noradrenaline | multiple interactions | ISO | RGD:737467 | 6480464 | Norepinephrine binds to and results in increased activity of ADRB3 protein | CTD | PMID:1682311 PMID:14730417 |
| (R)-noradrenaline | multiple interactions | EXP | | 6480464 | 3-(2-ethylphenoxy)-1-(1,2,3,4-tetrahydronaphth-1-ylamino)-2-propanol oxalate inhibits the reaction [Norepinephrine results in increased activity of ADRB3 protein] | CTD | PMID:17622774 PMID:8569714 |
| (R)-noradrenaline | increases activity | EXP | | 6480464 | Norepinephrine results in increased activity of ADRB3 protein | CTD | PMID:17622774 PMID:8569714 |
| (R)-noradrenaline | multiple interactions | EXP | | 6480464 | Norepinephrine binds to and results in increased activity of ADRB3 protein | CTD | PMID:7815362 |
| (R)-noradrenaline | multiple interactions | EXP | | 6480464 | 3-(2-ethylphenoxy)-1-(1,2,3,4-tetrahydronaphth-1-ylamino)-2-propanol oxalate inhibits the reaction [Norepinephrine results in increased activity of ADRB3 protein] | CTD | PMID:8569714 PMID:17622774 |
| (R)-noradrenaline | multiple interactions | ISO | RGD:737467 | 6480464 | Octopamine inhibits the reaction [Norepinephrine binds to ADRB3 protein] | CTD | PMID:10344530 |
| 17alpha-ethynylestradiol | increases expression | EXP | | 6480464 | Ethinyl Estradiol results in increased expression of ADRB3 mRNA | CTD | PMID:15212814 |
| 17beta-estradiol | increases expression | ISO | RGD:10110 | 6480464 | Estradiol results in increased expression of ADRB3 mRNA | CTD | PMID:15713686 |
| 3',5'-cyclic AMP | multiple interactions | ISO | RGD:737467 | 6480464 | 3-(2-ethylphenoxy)-1-(1,2,3,4-tetrahydronaphth-1-ylamino)-2-propanol oxalate inhibits the reaction [[SR 59119A binds to and results in increased activity of ADRB3 protein] which results in increased abundance of Cyclic AMP] | CTD | PMID:10952688 |
| 3',5'-cyclic AMP | affects abundance | ISO | RGD:737467 | 6480464 | ADRB3 protein affects the abundance of Cyclic AMP | CTD | PMID:14730417 |
| 3',5'-cyclic AMP | multiple interactions | ISO | RGD:737467 | 6480464 | [BRL 37344 binds to and results in increased activity of ADRB3 protein] which results in increased abundance of Cyclic AMP; more ... | CTD | PMID:14730417 |
| 3,3',5-triiodo-L-thyronine | multiple interactions | EXP | | 6480464 | Amiodarone inhibits the reaction [Triiodothyronine results in decreased expression of ADRB3 protein] | CTD | PMID:10217540 |
| 3,3',5-triiodo-L-thyronine | increases expression | EXP | | 6480464 | Triiodothyronine results in increased expression of ADRB3 protein | CTD | PMID:8836703 |
| 3,3',5-triiodo-L-thyronine | decreases expression | EXP | | 6480464 | Triiodothyronine results in decreased expression of ADRB3 protein; more ... | CTD | PMID:10217540 |
| albuterol | multiple interactions | ISO | RGD:737467 | 6480464 | [Albuterol binds to and results in increased activity of ADRB3 protein] which results in increased abundance of Cyclic AMP; more ... | CTD | PMID:14730417 |
| alprenolol | multiple interactions | ISO | RGD:737467 | 6480464 | Alprenolol binds to and results in increased activity of ADRB3 protein; more ... | CTD | PMID:14730417 |
| amiodarone | multiple interactions | EXP | | 6480464 | Amiodarone inhibits the reaction [Triiodothyronine results in decreased expression of ADRB3 protein] | CTD | PMID:10217540 |
| ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of ADRB3 mRNA | CTD | PMID:16483693 |
| arsenite(3-) | decreases expression | ISO | RGD:10110 | 6480464 | arsenite results in decreased expression of ADRB3 mRNA | CTD | PMID:18191166 |
| atenolol | multiple interactions | ISO | RGD:737467 | 6480464 | Atenolol inhibits the reaction [cyanopindolol binds to ADRB3 protein] | CTD | PMID:14730417 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:10110 | 6480464 | [Benzo(a)pyrene co-treated with XPA gene mutant form co-treated with TRP53 gene mutant form] results in increased expression of ADRB3 mRNA | CTD | PMID:21715664 |
| benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of ADRB3 mRNA | CTD | PMID:22374506 |
| benzo[a]pyrene | decreases expression | ISO | RGD:10110 | 6480464 | Benzo(a)pyrene results in decreased expression of ADRB3 mRNA | CTD | PMID:22228805 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:10110 | 6480464 | AHR protein affects the reaction [Benzo(a)pyrene affects the expression of ADRB3 mRNA] | CTD | PMID:22228805 |
| bisoprolol | multiple interactions | ISO | RGD:737467 | 6480464 | Bisoprolol inhibits the reaction [cyanopindolol binds to ADRB3 protein] | CTD | PMID:14730417 |
| carvedilol | multiple interactions | ISO | RGD:737467 | 6480464 | carvedilol inhibits the reaction [cyanopindolol binds to ADRB3 protein] | CTD | PMID:14730417 |
| carvedilol | decreases expression | EXP | | 6480464 | carvedilol results in decreased expression of ADRB3 mRNA | CTD | PMID:17440824 |
| carvedilol | affects response to substance | ISO | RGD:10110 | 6480464 | ADRB3 affects the susceptibility to carvedilol | CTD | PMID:11159692 |
| CGP 12177 | multiple interactions | EXP | | 6480464 | 3-(2-ethylphenoxy)-1-(1,2,3,4-tetrahydronaphth-1-ylamino)-2-propanol oxalate inhibits the reaction [CGP 12177 results in increased activity of ADRB3 protein] | CTD | PMID:8569714 |
| CGP 12177 | affects binding | EXP | | 6480464 | CGP 12177 binds to ADRB3 protein | CTD | PMID:10217540 |
| CGP 12177 | affects response to substance | ISO | RGD:10110 | 6480464 | ADRB3 affects the susceptibility to CGP 12177 | CTD | PMID:11159692 |
| CGP 12177 | multiple interactions | ISO | RGD:737467 | 6480464 | [CGP 12177 binds to and results in increased activity of ADRB3 protein] which results in increased abundance of Cyclic AMP; more ... | CTD | PMID:14730417 |
| CGP 12177 | multiple interactions | ISO | RGD:737467 | 6480464 | CGP 12177 binds to and results in increased activity of ADRB3 protein | CTD | PMID:10952688 more ... |
| CGP 12177 | multiple interactions | EXP | | 6480464 | CGP 12177 binds to and results in increased activity of ADRB3 protein | CTD | PMID:7815362 |
| CGP 12177 | increases activity | EXP | | 6480464 | CGP 12177 results in increased activity of ADRB3 protein | CTD | PMID:8569714 |
| chloroprene | decreases expression | ISO | RGD:10110 | 6480464 | Chloroprene results in decreased expression of ADRB3 mRNA | CTD | PMID:23125180 |
| chlorpyrifos | decreases expression | EXP | | 6480464 | Chlorpyrifos results in decreased expression of ADRB3 mRNA | CTD | PMID:17452286 |
| chlorpyrifos | affects expression | EXP | | 6480464 | Chlorpyrifos affects the expression of ADRB3 mRNA | CTD | PMID:18812211 |
| choline | multiple interactions | ISO | RGD:10110 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of ADRB3 gene | CTD | PMID:20938992 |
| clenbuterol | multiple interactions | EXP | | 6480464 | Clenbuterol binds to and results in increased activity of ADRB3 protein | CTD | PMID:7815362 |
| clofibrate | multiple interactions | ISO | RGD:10110 | 6480464 | [Clofibrate co-treated with Acetaminophen] affects the expression of ADRB3 mRNA; more ... | CTD | PMID:17585979 |
| D-glucose | multiple interactions | ISO | RGD:10110 | 6480464 | [BRL 37344 binds to and results in increased activity of ADRB3 protein] which results in decreased abundance of Glucose | CTD | PMID:20930473 |
| dexamethasone | decreases expression | ISO | RGD:10110 | 6480464 | Dexamethasone results in decreased expression of ADRB3 mRNA | CTD | PMID:10725275 |
| diazinon | affects expression | EXP | | 6480464 | Diazinon affects the expression of ADRB3 mRNA | CTD | PMID:18812211 |
| diazinon | decreases expression | EXP | | 6480464 | Diazinon results in decreased expression of ADRB3 mRNA | CTD | PMID:17452286 |
| diazoxide | multiple interactions | ISO | RGD:737467 | 6480464 | Isoproterenol binds to and results in increased activity of ADRB3 protein | CTD | PMID:1682311 |
| diazoxide | multiple interactions | ISO | RGD:737467 | 6480464 | Isoproterenol binds to and results in increased activity of ADRB3 protein | CTD | PMID:14730417 PMID:1682311 |
| diazoxide | multiple interactions | ISO | RGD:10110 | 6480464 | [ADRB3 affects the expression of ADRB1 mRNA] which affects the susceptibility to Isoproterenol | CTD | PMID:11159692 |
| diazoxide | multiple interactions | ISO | RGD:737467 | 6480464 | Isoproterenol inhibits the reaction [cyanopindolol binds to ADRB3 protein]; more ... | CTD | PMID:14730417 |
| diazoxide | increases expression | EXP | | 6480464 | Isoproterenol results in increased expression of ADRB3 mRNA | CTD | PMID:20654104 PMID:15009959 |
| diazoxide | increases expression | EXP | | 6480464 | Isoproterenol results in increased expression of ADRB3 protein | CTD | PMID:15009959 |
| diazoxide | increases expression | EXP | | 6480464 | Isoproterenol results in increased expression of ADRB3 mRNA | CTD | PMID:15009959 PMID:20654104 |
| diazoxide | increases activity | EXP | | 6480464 | Isoproterenol results in increased activity of ADRB3 protein | CTD | PMID:17622774 |
| diazoxide | multiple interactions | EXP | | 6480464 | Isoproterenol binds to and results in increased activity of ADRB3 protein | CTD | PMID:7815362 |
| diazoxide | multiple interactions | EXP | | 6480464 | 3-(2-ethylphenoxy)-1-(1,2,3,4-tetrahydronaphth-1-ylamino)-2-propanol oxalate inhibits the reaction [Isoproterenol results in increased expression of ADRB3 protein] | CTD | PMID:20654104 |
| diazoxide | multiple interactions | EXP | | 6480464 | BRL 37344 promotes the reaction [Isoproterenol results in increased expression of ADRB3 mRNA]; more ... | CTD | PMID:15009959 |
| diazoxide | multiple interactions | EXP | | 6480464 | 3-(2-ethylphenoxy)-1-(1,2,3,4-tetrahydronaphth-1-ylamino)-2-propanol oxalate inhibits the reaction [Isoproterenol results in increased activity of ADRB3 protein] | CTD | PMID:17622774 |
| diazoxide | multiple interactions | ISO | RGD:737467 | 6480464 | L 748,337 inhibits the reaction [Isoproterenol results in increased activity of ADRB3 protein] | CTD | PMID:18820136 |
| diazoxide | increases activity | ISO | RGD:737467 | 6480464 | Isoproterenol results in increased activity of ADRB3 protein | CTD | PMID:18820136 |
| diethylstilbestrol | increases expression | EXP | | 6480464 | Diethylstilbestrol results in increased expression of ADRB3 mRNA | CTD | PMID:21658437 |
| dobutamine | multiple interactions | EXP | | 6480464 | [Dobutamine co-treated with ICI 118551] results in increased expression of ADRB3 mRNA; more ... | CTD | PMID:19719783 |
| fenoterol | multiple interactions | ISO | RGD:737467 | 6480464 | Fenoterol binds to and results in increased activity of ADRB3 protein; more ... | CTD | PMID:14730417 |
| folic acid | multiple interactions | ISO | RGD:10110 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of ADRB3 gene | CTD | PMID:20938992 |
| formoterol | multiple interactions | ISO | RGD:737467 | 6480464 | formoterol binds to and results in increased activity of ADRB3 protein; more ... | CTD | PMID:14730417 |
| glucose | multiple interactions | ISO | RGD:10110 | 6480464 | [BRL 37344 binds to and results in increased activity of ADRB3 protein] which results in decreased abundance of Glucose | CTD | PMID:20930473 |
| griseofulvin | decreases expression | ISO | RGD:10110 | 6480464 | Griseofulvin results in decreased expression of ADRB3 mRNA | CTD | PMID:12735108 |
| hydroquinone O-beta-D-glucopyranoside | decreases expression | ISO | RGD:737467 | 6480464 | Arbutin results in decreased expression of ADRB3 mRNA | CTD | PMID:17103032 |
| isoprenaline | multiple interactions | ISO | RGD:737467 | 6480464 | Isoproterenol binds to and results in increased activity of ADRB3 protein | CTD | PMID:1682311 |
| isoprenaline | increases expression | EXP | | 6480464 | Isoproterenol results in increased expression of ADRB3 mRNA | CTD | PMID:15009959 PMID:20654104 |
| isoprenaline | multiple interactions | ISO | RGD:737467 | 6480464 | Isoproterenol binds to and results in increased activity of ADRB3 protein | CTD | PMID:14730417 PMID:1682311 |
| isoprenaline | multiple interactions | ISO | RGD:10110 | 6480464 | [ADRB3 affects the expression of ADRB1 mRNA] which affects the susceptibility to Isoproterenol | CTD | PMID:11159692 |
| isoprenaline | multiple interactions | ISO | RGD:737467 | 6480464 | Isoproterenol inhibits the reaction [cyanopindolol binds to ADRB3 protein]; more ... | CTD | PMID:14730417 |
| isoprenaline | increases expression | EXP | | 6480464 | Isoproterenol results in increased expression of ADRB3 mRNA | CTD | PMID:20654104 PMID:15009959 |
| isoprenaline | increases expression | EXP | | 6480464 | Isoproterenol results in increased expression of ADRB3 protein | CTD | PMID:15009959 |
| isoprenaline | increases activity | EXP | | 6480464 | Isoproterenol results in increased activity of ADRB3 protein | CTD | PMID:17622774 |
| isoprenaline | multiple interactions | EXP | | 6480464 | Isoproterenol binds to and results in increased activity of ADRB3 protein | CTD | PMID:7815362 |
| isoprenaline | multiple interactions | EXP | | 6480464 | BRL 37344 promotes the reaction [Isoproterenol results in increased expression of ADRB3 protein]; more ... | CTD | PMID:15009959 |
| isoprenaline | multiple interactions | EXP | | 6480464 | 3-(2-ethylphenoxy)-1-(1,2,3,4-tetrahydronaphth-1-ylamino)-2-propanol oxalate inhibits the reaction [Isoproterenol results in increased expression of ADRB3 protein] | CTD | PMID:20654104 |
| isoprenaline | multiple interactions | EXP | | 6480464 | 3-(2-ethylphenoxy)-1-(1,2,3,4-tetrahydronaphth-1-ylamino)-2-propanol oxalate inhibits the reaction [Isoproterenol results in increased activity of ADRB3 protein] | CTD | PMID:17622774 |
| isoprenaline | multiple interactions | ISO | RGD:737467 | 6480464 | L 748,337 inhibits the reaction [Isoproterenol results in increased activity of ADRB3 protein] | CTD | PMID:18820136 |
| isoprenaline | increases activity | ISO | RGD:737467 | 6480464 | Isoproterenol results in increased activity of ADRB3 protein | CTD | PMID:18820136 |
| kojic acid | decreases expression | ISO | RGD:737467 | 6480464 | kojic acid results in decreased expression of ADRB3 mRNA | CTD | PMID:16595896 |
| L-methionine | multiple interactions | ISO | RGD:10110 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of ADRB3 gene | CTD | PMID:20938992 |
| lactic acid | multiple interactions | ISO | RGD:10110 | 6480464 | [BRL 37344 binds to and results in increased activity of ADRB3 protein] which results in increased abundance of Lactic Acid | CTD | PMID:20930473 |
| metoprolol | multiple interactions | EXP | | 6480464 | Metoprolol promotes the reaction [Streptozocin results in increased expression of ADRB3 protein] | CTD | PMID:18703049 |
| metoprolol | multiple interactions | ISO | RGD:737467 | 6480464 | Metoprolol inhibits the reaction [cyanopindolol binds to ADRB3 protein] | CTD | PMID:14730417 |
| metoprolol | increases expression | EXP | | 6480464 | Metoprolol results in increased expression of ADRB3 protein | CTD | PMID:18703049 |
| N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of ADRB3 mRNA | CTD | PMID:18164116 |
| octopamine | increases activity | EXP | | 6480464 | Octopamine results in increased activity of ADRB3 protein | CTD | PMID:10344530 |
| octopamine | multiple interactions | ISO | RGD:737467 | 6480464 | Octopamine inhibits the reaction [Norepinephrine binds to ADRB3 protein] | CTD | PMID:10344530 |
| ozone | decreases expression | ISO | RGD:10110 | 6480464 | Ozone results in decreased expression of ADRB3 mRNA | CTD | PMID:12763052 PMID:17460151 |
| ozone | decreases expression | ISO | RGD:10110 | 6480464 | Ozone results in decreased expression of ADRB3 mRNA | CTD | PMID:17460151 PMID:12763052 |
| paracetamol | multiple interactions | ISO | RGD:10110 | 6480464 | [Clofibrate co-treated with Acetaminophen] affects the expression of ADRB3 mRNA; more ... | CTD | PMID:17585979 |
| paracetamol | affects expression | ISO | RGD:10110 | 6480464 | Acetaminophen affects the expression of ADRB3 mRNA | CTD | PMID:17562736 |
| paracetamol | decreases expression | ISO | RGD:10110 | 6480464 | Acetaminophen results in decreased expression of ADRB3 mRNA | CTD | PMID:17585979 |
| phenylephrine | multiple interactions | ISO | RGD:737467 | 6480464 | SR 58611A inhibits the reaction [ADRB3 protein results in increased susceptibility to Phenylephrine]; more ... | CTD | PMID:16022967 |
| phenylephrine | increases response to substance | ISO | RGD:737467 | 6480464 | ADRB3 protein results in increased susceptibility to Phenylephrine | CTD | PMID:16022967 |
| phenytoin | decreases expression | EXP | | 6480464 | Phenytoin results in decreased expression of ADRB3 mRNA | CTD | PMID:20345932 |
| pindolol | multiple interactions | ISO | RGD:737467 | 6480464 | Pindolol binds to and results in increased activity of ADRB3 protein | CTD | PMID:1682311 |
| pindolol | multiple interactions | ISO | RGD:737467 | 6480464 | Pindolol binds to and results in increased activity of ADRB3 protein | CTD | PMID:1682311 PMID:14730417 |
| pindolol | multiple interactions | ISO | RGD:737467 | 6480464 | [Pindolol binds to and results in increased activity of ADRB3 protein] which results in increased abundance of Cyclic AMP; more ... | CTD | PMID:14730417 |
| pindolol | multiple interactions | ISO | RGD:737467 | 6480464 | Pindolol binds to and results in increased activity of ADRB3 protein | CTD | PMID:14730417 PMID:1682311 |
| pindolol | multiple interactions | EXP | | 6480464 | Pindolol binds to and results in increased activity of ADRB3 protein | CTD | PMID:7815362 |
| pirinixic acid | decreases expression | ISO | RGD:10110 | 6480464 | pirinixic acid results in decreased expression of ADRB3 mRNA | CTD | PMID:17950772 |
| pirinixic acid | multiple interactions | ISO | RGD:10110 | 6480464 | PPARA protein promotes the reaction [pirinixic acid results in decreased expression of ADRB3 mRNA] | CTD | PMID:17950772 |
| pirinixic acid | increases expression | ISO | RGD:10110 | 6480464 | pirinixic acid results in increased expression of ADRB3 mRNA | CTD | PMID:16306350 |
| progesterone | increases expression | ISO | RGD:10110 | 6480464 | Progesterone results in increased expression of ADRB3 mRNA | CTD | PMID:15713686 |
| propranolol | multiple interactions | ISO | RGD:737467 | 6480464 | Propranolol inhibits the reaction [cyanopindolol binds to ADRB3 protein] | CTD | PMID:14730417 |
| propranolol | affects response to substance | ISO | RGD:10110 | 6480464 | ADRB3 affects the susceptibility to Propranolol | CTD | PMID:11159692 |
| pyruvic acid | multiple interactions | ISO | RGD:10110 | 6480464 | [BRL 37344 binds to and results in increased activity of ADRB3 protein] which results in increased abundance of Pyruvic Acid | CTD | PMID:20930473 |
| rosiglitazone | decreases expression | ISO | RGD:10110 | 6480464 | rosiglitazone results in decreased expression of ADRB3 mRNA | CTD | PMID:16306350 |
| rosiglitazone | decreases expression | ISO | RGD:737467 | 6480464 | rosiglitazone results in decreased expression of ADRB3 protein | CTD | PMID:17970706 |
| salmeterol | multiple interactions | ISO | RGD:737467 | 6480464 | salmeterol binds to and results in decreased activity of ADRB3 protein; more ... | CTD | PMID:14730417 |
| streptozocin | multiple interactions | EXP | | 6480464 | Metoprolol promotes the reaction [Streptozocin results in increased expression of ADRB3 protein] | CTD | PMID:18703049 |
| streptozocin | increases expression | EXP | | 6480464 | Streptozocin results in increased expression of ADRB3 protein | CTD | PMID:18703049 |
| terbutaline | multiple interactions | ISO | RGD:737467 | 6480464 | Terbutaline binds to and results in increased activity of ADRB3 protein | CTD | PMID:14730417 PMID:16648137 |
| terbutaline | multiple interactions | ISO | RGD:737467 | 6480464 | Terbutaline inhibits the reaction [cyanopindolol binds to ADRB3 protein]; more ... | CTD | PMID:14730417 |
| terbutaline | multiple interactions | EXP | | 6480464 | Terbutaline binds to and results in increased activity of ADRB3 protein | CTD | PMID:7815362 |